Shenzhen Salubris Pharmaceuticals Co Ltd Financial Flexibility Index

Latest as of September 2025: 0.34x

Shenzhen Salubris Pharmaceuticals Co Ltd financial flexibility index. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Financial Flexibility Index of 0.34x as of September 2025. Free cash flow of CN¥692.94 Million (operating CF CN¥400.70 Million minus capex CN¥292.24 Million) represents 0% of total liabilities (CN¥2.05 Billion). Explore reinvestment intensity of Shenzhen Salubris Pharmaceuticals Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.

Financial Flexibility Index

0.34x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥692.94 Million
Operating CF − Capex

Total Liabilities

CN¥2.05 Billion
CNY

Capital Expenditures

CN¥292.24 Million
CNY

Financial Flexibility Index of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

Financial flexibility index of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. Historical Financial Flexibility Index trend for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Check 002294 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Shenzhen Salubris Pharmaceuticals Co Ltd Financial Flexibility Index by Year (2006–2024)

Shenzhen Salubris Pharmaceuticals Co Ltd financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Shenzhen Salubris Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see 002294 cash flow conversion.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2024 1.06x CN¥1.81 Billion CN¥1.19 Billion CN¥1.71 Billion ▼ -8.0%
2023 1.15x CN¥1.54 Billion CN¥869.79 Million CN¥1.34 Billion ▲ +30.2%
2022 0.88x CN¥1.57 Billion CN¥970.80 Million CN¥1.78 Billion ▼ -36.6%
2021 1.39x CN¥1.67 Billion CN¥1.18 Billion CN¥1.20 Billion ▼ -8.4%
2020 1.52x CN¥2.02 Billion CN¥1.37 Billion CN¥1.33 Billion ▼ -17.4%
2019 1.84x CN¥1.96 Billion CN¥1.51 Billion CN¥1.07 Billion ▲ +13.7%
2018 1.62x CN¥1.67 Billion CN¥1.34 Billion CN¥1.03 Billion ▼ -36.1%
2017 2.54x CN¥1.79 Billion CN¥1.46 Billion CN¥705.86 Million ▲ +62.1%
2016 1.56x CN¥1.68 Billion CN¥1.43 Billion CN¥1.07 Billion ▼ -16.3%
2015 1.87x CN¥1.29 Billion CN¥1.06 Billion CN¥691.25 Million ▲ +30.8%
2014 1.43x CN¥1.18 Billion CN¥982.25 Million CN¥827.95 Million ▼ -33.7%
2013 2.16x CN¥1.10 Billion CN¥668.52 Million CN¥508.36 Million ▼ -0.2%
2012 2.16x CN¥807.96 Million CN¥521.21 Million CN¥374.02 Million ▲ +27.8%
2011 1.69x CN¥524.92 Million CN¥272.32 Million CN¥310.52 Million ▲ +27.6%
2010 1.33x CN¥410.13 Million CN¥186.65 Million CN¥309.50 Million ▼ -27.1%
2009 1.82x CN¥269.96 Million CN¥134.28 Million CN¥148.59 Million ▲ +89.9%
2008 0.96x CN¥139.37 Million CN¥77.89 Million CN¥145.70 Million ▲ +58.3%
2007 0.60x CN¥66.46 Million CN¥52.75 Million CN¥109.98 Million ▲ +45.3%
2006 0.42x CN¥21.71 Million CN¥12.00 Million CN¥52.19 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities